Fig 2. CD14^dimCD16+ cells were at increased frequency in AMs of CBD, while CD14^brightCD16+ cells at increased frequency in AMs of BeS.

2a. A representative example of AMs gates from fresh BAL cells from CBD patients. 2b. The expression of CD14 and CD16 using the AMs gate. In the representative examples shown, 85.9% of AM were with a CD14^dimCD16+ phenotype while only 6.06% of AM with a CD14^brightCD16+ phenotype. 2c. The expression of HLA-DR using the AMs gate. 95.2% of AMs highly expressed HLA-DR. 2d. Frequency of CD14^dimCD16+ cells among total AMs from HS and patients with BeS-NS and CBD. Each dot represents an individual subjects. 2e. Frequency of CD14^brightCD16+ cells among total AMs from HS and patients with BeS-NS and CBD. Each dot represents an individual subjects. **p<0.01.